NCT01173770View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ADC3680B in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

ADC3680B

Escalating single doses ADC3680B or Placebo over 5 study periods

DRUG

ADC3680B

ADC3680B or Placebo for 7 days

DRUG

ADC3680B

Single doses ADC3680B over 2 study periods under fasted and fed conditions

Trial Locations (1)

CF48 4DR

Simbec, Merthyr Tydfil

Sponsors
All Listed Sponsors
lead

Pulmagen Therapeutics

INDUSTRY